Latest News about APLS
Recent news which mentions APLS
Why Owlet Shares Are Trading Higher By Over 45%; Here Are 20 Stocks Moving Premarket
February 21, 2023
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
February 20, 2023
From Benzinga
From Benzinga
Will 2023 be the year that pharma M&A makes a comeback?
January 12, 2023
From MarketWatch
What 5 Analyst Ratings Have To Say About Apellis Pharmaceuticals
January 03, 2023
Tickers
APLS
From Benzinga
From Benzinga
Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday
November 21, 2022
From Benzinga
From Benzinga
Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
November 18, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
November 18, 2022
From Benzinga
Apellis Pharma Shares Jump As FDA Accepts Its Lead Product Application For Eye Disease
November 18, 2022
Tickers
APLS
From Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
November 18, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
November 17, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 10, 2022
November 10, 2022
From Benzinga
5 Analysts Have This to Say About Apellis Pharmaceuticals
November 08, 2022
Tickers
APLS
From Benzinga
Yelp, Twilio, Atlassian, And Other Big Losers From Friday
November 07, 2022
From Benzinga
From Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
From Benzinga
Why Are Apellis Pharmaceuticals Shares Falling Today?
November 04, 2022
From Benzinga
From Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
From Benzinga
7 Analysts Have This to Say About Apellis Pharmaceuticals
October 18, 2022
Tickers
APLS
From Benzinga
From Benzinga
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
October 03, 2022
From Benzinga
Investigator Says Apellis' Lead Product Shows 'First Direct Evidence Of Slowing Geographic Atrophy Lesion Growth'
October 03, 2022
Tickers
APLS
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 29, 2022
From Benzinga
Stifel Maintains Buy Rating for Apellis Pharmaceuticals: Here's What You Need To Know
September 08, 2022
Tickers
APLS
From Benzinga
Moderna To $165? Plus This Analyst Cuts PT On FedEx
September 08, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.